Cargando…
Immunotherapy of Neuromyelitis Optica
Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy. There is a growing body of evidence that immunotherapeutic agents targeting T and B cell functions, as well as activ...
Autores principales: | Bienia, Benjamin, Balabanov, Roumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886592/ https://www.ncbi.nlm.nih.gov/pubmed/24455211 http://dx.doi.org/10.1155/2013/741490 |
Ejemplares similares
-
Can Immune Tolerance Be Re-established in Neuromyelitis Optica?
por: Loda, Eileah, et al.
Publicado: (2021) -
Case report: Use of granulocyte-colony stimulating factor as an immunomodulatory therapy in a patient with neuromyelitis optica spectrum disorder and comorbid immunodeficiency
por: Perez Giraldo, Gina S., et al.
Publicado: (2023) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953) -
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)